A prestigious EU-grant will advance OncoImmunity’s machine-learning approach to develop personalized cancer immunotherapy. The bioinformatics company OncoImmunity AS is empowering cancer immunotherapy with artificial intelligence. They use innovative software solutions to guide the discovery of neoantigen-based personalized immunotherapies and biomarkers. What does this really mean? It means that the software they have developed helps to identify […]
Author Archive for: oslocancer
This author has yet to write their bio.Meanwhile lets just say that we are proud oslocancer contributed a whooping 350 entries.
Entries by oslocancer
Kongsberg Beam Technology wants to direct the precision technology from advanced industrial control systems to hit tumors in the human body. — We want to use Norwegian spearhead technology to combat cancer, Per Håvard Kleven said from the stage as he pitched the idea of his start-up at the DNB Nordic Healthcare Conference 2018. He is […]
Hannah (18) wants to become a doctor. After two days job shadowing doctors and nurses at the Norwegian Radium Hospital, she is even more certain that this is what she wants to do. If your dream is to become a doctor, it may be a good idea to gain some insight into what the job […]
Roche is looking for new partners in the innovative Norwegian life science scene. Roche is one of the largest pharmaceutical companies in the world with about 800 ongoing clinical trials. Within cancer research and development, this translates into about 500 clinical trials for many different types of cancer. Roche is a member in Oslo Cancer Cluster. […]
Starting next year, Oslo Cancer Cluster will co-power the conference E-health in Norway (EHiN). – This is a natural continuation of the work we do in digitalisation, for a better understanding of cancer and better patient treatment, said Ketil Widerberg, General Manager of Oslo Cancer Cluster, at this year’s conference. The Norwegian Ministry of Health and Care […]
International cooperation is key to fulfilling our vision of making cancer treatments more precise, and giving the patients new treatments more quickly. This opinion piece is written by Ketil Widerberg, General Manager at Oslo Cancer Cluster. It was first published in the Norwegian newspaper Today’s Medicine, Dagens Medisin, 30 October 2018. The countries in Northern Europe have […]
Meet Thomas Andersson, our new Senior Advisor Business Development. How could he be of help to your startup company? — The most important thing I do is to get the startup companies rolling. Thomas Andersson, the new Senior Advisor for Business Development at Oslo Cancer Cluster and Oslo Cancer Cluster Incubator, looks dead serious as […]
What does the Nobel Prize have to do with cancer research in Oslo Cancer Cluster? This year the Nobel Prize for Physiology and Medicine was awarded to James P. Allison and Tasuku Honjo for their work on unleashing the body’s immune system to attack cancer. This was a breakthrough that has led to an entirely new class […]
Oslo Cancer Cluster member Vaccibody is entering into a clinical collaboration with the American biopharmaceutical company Nektar Therapeutics. The aim of the collaboration is to explore positive effects from the combination of Vaccibody’s personalized cancer vaccine VB10.NEO and Nektar Therapeutics cancer drug NKTR-214. Pre-clinical results of the combination are very positive and the collaboration will […]
Combining country scale population data with world class computer systems and algorithms will push the boundaries of precision medicine. This is a story about the unique American-Norwegian collaboration that combines the best health data with the most powerful computers in a pioneer project run by Cancer Registry of Norway and Lawrence Livermore National Laboratory. Data to screen […]
Contact Team >
Oslo Cancer Cluster Incubator will support promising oncology biotechs to commercialize successfully.
The Incubator provides a dynamic, creative, and professional growth environment for scientists and start-ups.